HEALTHSTORY 521· JULY 1, 2026

Anthropic to Develop Its Own Drugs, Testing Whether AI Can Do Real Science

Anthropic, the San Francisco-based artificial intelligence company behind the Claude family of models, announced Tuesday that it will enter drug development — a significant step that tests whether AI systems can do genuine scientific work…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 520First Horizon Bank Executive Daniel Maurin Joins Junior Achievement of Greater New Orleans Board of Governors NEXT STORY 522 →LG UltraGear 27GX700A-B Falls to $484.99, Near Its All-Time Low

Keep reading

More from the desk.

12HEALTH

FDA clears Replimune's melanoma drug Tudriqev after two rejections

A cancer treatment rejected twice by federal regulators has now won approval. The Food and Drug Administration granted accelerated approval to Tudriqev, a drug made by the biotech company Replimune, for patients with advanced melanoma…

health2 MIN

50HEALTH

Seven months after launch, Aurora Therapeutics scraps its lead gene-editing program and cuts staff

Personalized CRISPR therapies, gene-editing treatments built around one patient's specific mutation rather than a disease shared by millions, just lost one of their early backers. Aurora Therapeutics has scrapped its lead program and laid…

health2 MIN

65HEALTH

California Supreme Court rules Gilead Sciences has no legal duty to fast-track a safer HIV drug

Pharmaceutical companies do not owe patients a legal duty to speed up development of a safer drug simply because a less safe version is already on the market. That concept, called a "duty to innovate," was at the center of a case brought…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk